Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 39kWORD 9k
29 January 2020
E-000546/2020
Question for written answer E-000546/2020
to the Commission
Rule 138
Tomislav Sokol (PPE)
 Answer in writing 
 Subject: Improving the efficiency of health systems

According to the World Health Organisation (WHO), cancer causes almost 20% of deaths in Europe. More than 3 million cases of cancer are reported each year, and approximately 1.7 million people die each year of cancer. After various cardiovascular diseases, cancer is the second largest cause of death and illness in Europe.

Regardless of the resources available to them, all states can apply the basic elements of dealing with cancer, which are: prevention, early detection, diagnosis and treatment so that various cancers can be prevented and cured. Cancer is avoidable in many cases, and the early detection process greatly increases the chance of successful treatment. It is therefore important to keep in mind that investing in cancer control is an investment in the future and in the health of society.

1. How does the Commission intend to promote efficiency and ensure uniform standards in health systems throughout the EU?

2. Does the Commission plan to allocate more funding to healthcare (innovative medicines and treatments) in the new MFF, especially with regard to Southeast European Member States, which are financially lagging behind the European standard?

Original language of question: HR
Last updated: 25 September 2020Legal notice - Privacy policy